Small pharmaceutical and biotech companies have many obstacles to consider in order to initiate, supply, and resupply clinical studies successfully. In this recording, our expert Mark Shepanski, Executive Director of Operations, San Diego Site Leader, discusses a few considerations small companies should take into account when developing clinical supply strategies such as:
- Building in agility and speed into the clinical supply chain
- Optimizing limited drug supplies
- Parallel processing